Loading clinical trials...

Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging) | Clinical Trials | Clareo Health

TERMINATED

Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)

NCT06445127•Johns Hopkins University

View on ClinicalTrials.gov

Summary

This study is being done to find out if a non-invasive Magnetic Resonance Imaging (MRI) examination of the kidneys may be helpful in patients with systemic lupus erythematosus (SLE).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Male and female adults over the age of 18 who have been diagnosed with SLE and are able to undergo a kidney MRI.

Exclusion Criteria

•Any patient that has undergone a renal transplant.
•Any patient that is receiving renal dialysis

Locations (1)

Johns Hopkins University School of Medicine

Baltimore, Maryland, United States

Key Dates

Start Date

May 7, 2024

Primary Completion Date

January 1, 2025

Completion Date

April 8, 2025

Last Updated

May 7, 2025

Enrollment

ACTUAL participants

Conditions

SLE (Systemic Lupus)

Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

NCT07237659

SLE (Systemic Lupus)RA - Rheumatoid Arthritis

View study

NOT_YET_RECRUITINGPHASE2

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

NCT06971913

SLE (Systemic Lupus)CMV

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 7, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions